We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+14.8%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.85B
AUM Growth
+$181M
Cap. Flow
+$27.3M
Cap. Flow %
1.48%
Top 10 Hldgs %
26.18%
Holding
272
New
16
Increased
74
Reduced
154
Closed
22

Top Buys

Rank Stock Value
1
WEX icon
WEX
WEX
+$25M
2
DOX icon
Amdocs
DOX
+$10.9M
3
ETSY icon
Etsy
ETSY
+$9.39M
4
GNTX icon
Gentex
GNTX
+$8.86M
5
MGPI icon
MGP Ingredients
MGPI
+$6.5M

Top Sells

Rank Stock Value
1
AX icon
Axos Financial
AX
+$16.8M
2
PCRX icon
Pacira BioSciences
PCRX
+$12.5M
3
ADMA icon
ADMA Biologics
ADMA
+$11.5M
4
ACIW icon
ACI Worldwide
ACIW
+$9.89M
5
RXO icon
RXO
RXO
+$8.37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.6%
2 Technology 28.67%
3 Industrials 15.74%
4 Consumer Staples 6.67%
5 Communication Services 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXEL icon
226
Exelixis
EXEL
$13.1B
$539K 0.03%
20,766
-645
-3% -$16K
KNX icon
227
Knight Transportation
KNX
$11.2B
$526K 0.03%
9,748
-297
-3% -$15.4K
ZBH icon
228
Zimmer Biomet
ZBH
$18.7B
$522K 0.03%
4,834
-113
-2% -$12.3K
KBR icon
229
KBR
KBR
$4.83B
$509K 0.03%
7,814
-177
-2% -$11.5K
CVX icon
230
Chevron
CVX
$382B
$497K 0.03%
3,377
-360
-10% -$53.6K
FMC icon
231
FMC
FMC
$1.31B
$465K 0.03%
7,045
+52
+0.7% +$3.19K
J icon
232
Jacobs Solutions
J
$17.2B
$464K 0.03%
3,580
-706
-16% -$85.1K
SRRK icon
233
Scholar Rock
SRRK
$6.32B
$455K 0.02%
56,761
+10,761
+23% +$94.5K
EW icon
234
Edwards Lifesciences
EW
$53B
$433K 0.02%
6,555
-150
-2% -$10.9K
SYY icon
235
Sysco
SYY
$40.1B
$429K 0.02%
5,496
-17
-0.3% -$1.28K
GBCI icon
236
Glacier Bancorp
GBCI
$6.35B
$427K 0.02%
9,339
-73
-0.8% -$3.15K
DLB icon
237
Dolby
DLB
$5.82B
$409K 0.02%
5,344
-157
-3% -$11.7K
XOM icon
238
ExxonMobil
XOM
$662B
$400K 0.02%
3,413
JPM icon
239
JPMorgan Chase
JPM
$956B
$397K 0.02%
1,882
-176
-9% -$37.1K
WDFC icon
240
WD-40
WDFC
$3.15B
$348K 0.02%
1,350
WMT icon
241
Walmart Inc
WMT
$897B
$343K 0.02%
4,248
DVN icon
242
Devon Energy
DVN
$49.9B
$325K 0.02%
8,308
-235
-3% -$10.3K
COLM icon
243
Columbia Sportswear
COLM
$2.92B
$316K 0.02%
3,796
-118
-3% -$9.47K
MSFT icon
244
Microsoft
MSFT
$3.76T
$313K 0.02%
728
-15
-2% -$6.41K
MRSH
245
Marsh
MRSH
$91B
$301K 0.02%
1,350
CXT icon
246
Crane NXT
CXT
$2.96B
$266K 0.01%
4,739
-145
-3% -$8.42K
MCO icon
247
Moody's
MCO
$82.8B
$265K 0.01%
558
-315
-36% -$146K
PG icon
248
Procter & Gamble
PG
$340B
$263K 0.01%
1,519
-540
-26% -$91.7K
HAS icon
249
Hasbro
HAS
$13.3B
$250K 0.01%
3,455
-47
-1% -$3.05K
SBUX icon
250
Starbucks
SBUX
$119B
$241K 0.01%
+2,468
New +$212K

Similar funds

Rice Hall James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Rice Hall James & Associates held 272 positions worth $1.85B, up 11% from $1.67B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rice Hall James & Associates's Q3 2024 filing shows 16 new, 74 increased, 154 reduced and 22 closed positions. Its largest new stake was Gentex: 285,297 shares worth $8.47M. The largest sale was Axos Financial, an estimated $16.8M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q3 2024 buy was Gentex: 285,297 shares worth $8.47M.
  • Rice Hall James & Associates added most to WEX in Q3 2024, an estimated $25M increase.
  • Rice Hall James & Associates's biggest Q3 2024 reduction was Axos Financial, cutting an estimated $16.8M.
  • Rice Hall James & Associates fully exited RXO in Q3 2024, selling an estimated $8.37M.
  • Rice Hall James & Associates's ten largest holdings make up 26% of its $1.85B portfolio in Q3 2024.
  • Rice Hall James & Associates opened 16 new positions and closed 22 in Q3 2024.
  • Rice Hall James & Associates's portfolio value rose 11% quarter-over-quarter to $1.85B.

Based on Rice Hall James & Associates's 13F filing for Q3 2024, filed 28 Oct 2024.